Steven Perrin, PhD

Steven Perrin, PhD, is president and CSO at Eledon. He came to Eledon as founder and chief executive of Anelixis Therapeutics. Prior to this, he held research and development roles at the Hoechst-Ariad Genomics Center, Aventis Pharmaceuticals, and Biogen Idec. He also spent a decade with the ALS Therapy Development Institute, building its drug development program and bridging its preclinical and clinical work. He earned his doctorate in biochemistry at Boston University Medical Center, where he began his career as an associate professor of medicine.

Affiliation

President and Chief Scientific Officer, Eledon Pharmaceuticals

Location

Irvine, California, U.S.